Compositions Comprising a Physiological Coolant

ABSTRACT

The present invention concerns enhancements in the cooling effects of certain physiological coolant-containing compositions such as topically applied cosmetic, toiletry or pharmaceutical products, wherein the cooling effect of the physiological coolants is enhanced by the addition of a substance according to formula (I) or dermatologically acceptable salts thereof: 
       R 1 —CR 2 (OR 3 )—CO—NR 4 —CR 5 R 6 —X—OR 7   (I) 
     It was found that substances represented by formula (I) are capable of bringing about greater cooling effects from reduced concentrations of physiological coolants without behaving as physiological coolants themselves, thereby enabling the preparation of compositions that do not necessarily have the characteristic minty odour of menthol-containing products and/or to allow greater freedom in creating perfumed products.

FIELD OF THE INVENTION

The present invention concerns improvement in the cooling effects of compositions such as topically applied cosmetics, toiletries and pharmaceutics.

BACKGROUND OF THE INVENTION

Physiological cooling agents are used in topical formulations to impart a cooling sensation to the skin. These do not actually cool the skin temperature but interact with the cold and hot receptors present in the skin to give the individual the perception of a cool or warm feeling. The exact mechanism of the interaction between the cooling agent and the nerve receptors is not fully understood but, without wishing to be bound by theory, it is believed that physiological cooling agents affect calcium channels or the calcium transport associated with a number of receptors found in the skin. This interaction causes a greater stimulation of the nerve receptors giving rise to the perception of cold or hot.

Menthol is probably the best known of all the physiological cooling agents and is obtained from various species of mint plant (e.g. Mentha arvensis). Menthol is relatively cheap and effective but has the disadvantage that it has a strong mint-like odour. In addition, the cooling or warming lasts for a relatively short period of time when applied to skin, typically, one or two hours.

A number of compounds have been developed based on the structure of menthol or using the structure and/or the cooling effect of menthol as a guide to the synthesis of a new cooling compound. Such synthetic physiological cooling agents include: menthol esters, menthol ethers, menthone derivatives, menthane derivatives, etc. These compounds have the advantage that they do not tend to have a mint-like odour and so are more pleasant to use; the topically applied product and the skin do not have to smell of mint to provide a cooling sensation.

A number of recent articles have reviewed ingredients claimed to provide a skin cooling sensation:

-   -   “Progress in Physiological Cooling agents”, Mark Ermann,         Perfumery & Flavourist, Vol. 29, November/December 2004     -   “Cool Without Menthol & Cooler than Menthol and Cooling         Compounds as Insect Repellents”, John C. Leffingwell,         Leffingwell & Associates, 2006

In order to obtain a strong cooling effect on the skin, quite high levels of physiological cooling agents need to be incorporated into the topically applied formulation. Menthol, being one of the more effective cooling agents, is often used from around 0.01% w/w upwards in the formulation. Synthetic cooling agents based around the activity of menthol, such as those mentioned above, are used at higher levels, typically 0.05% w/w and upwards and often up to 2%. Since these synthetic cooling agents are expensive, there is a need to find ways to enhance their perceived cooling effect on the skin.

The present inventors have surprisingly found that substances represented by the following formula (I) can be used advantageously to improve the cooling effect of compositions such as, for example, cosmetics, toiletries and pharmaceutical products:

R¹—CR²(OR³)—CO—NR⁴—CR⁵R⁶—X—OR⁷  (I)

This is surprising, given that these materials do not act as a physiological coolant when used in isolation.

The present inventors found that the coolant-enhancing substances according to the present invention are particularly useful in a wide variety of topical applications, of which skin creams, lotions, gels, deodorant sticks and deodorant sprays are non-limiting examples.

Therefore, the present invention relates to topically applied cosmetic compositions, toiletries and pharmaceutical products comprising at least one substance according to formula (I) and at least one physiological coolant.

Furthermore, the present invention relates to the use of the substances according to formula (I) for improving the cooling effect of topically applied cosmetics, toiletries and pharmaceutical products.

SUMMARY OF THE INVENTION

Accordingly, in a first aspect, the present invention provides a composition comprising a physiological coolant and one or more coolant-enhancing substances according to formula (I), and/or physiologically- or dermatologically-acceptable salts thereof:

R¹⁻CR²(OR³)—CO—NR⁴—CR⁵R⁶—X—OR⁷  (I)

wherein: X represents a covalently bound radical selected from the group comprising C₁-C₅ alkyl or C₂-C₅ alkenyl, each optionally substituted with 1-4 substituents selected from hydroxyl, C₁-C₃ alkyl and C₁-C₃ alkenyl; R¹ and R² independently represent hydrogen; or C₁-C₈ alkyl, C₂-C₈ alkenyl or C₃-C₈ cycloalkyl, each optionally substituted with 1-8, preferably 1-6, substituents selected from hydroxyl, oxo, C₁-C₃ alkyl; C₂-C₃ alkenyl and C₁-C₃ carboxyl; R³ represents hydrogen, C₁-C₃ acyl or C₁-C₃ alkyl; R⁴ represents hydrogen; or C₁-C₆ alkyl, C₂-C₆ alkenyl, C₃-C₆ cycloalkyl, C₃-C₆ cycloalkenyl or C₁-C₆ acyl, each optionally substituted with 1-6 substituents selected from hydroxyl, C₁-C₃ alkyl and C₂-C₃ alkenyl; R⁵ and R⁶ independently represent hydrogen; hydroxyl; or C₁-C₈ alkyl, C₂-C₈ alkenyl, or C₃-C₈ cycloalkyl, each optionally substituted with 1-8 substituents selected from hydroxyl, C₁-C₃ alkyl and C₂-C₃ alkenyl; R⁷ represents hydrogen, C₁-C₃ acyl, C₁-C₃ alkyl, a phosphate group selected from mono-, di- and triphosphate or a C₂-C₅ carboxyacyl, optionally further substituted with 1-3 substituents selected from hydroxyl, oxo, C₁-C₃ carboxyl; provided that R¹—CR²(OR³)—CO— does not represent a hexose or heptose sugar acid residue comprising more than four hydroxyl groups.

In a second aspect, the invention provides a method of providing a cooling sensation to the skin, the method comprising topically applying a composition according to the invention to the skin.

In a third aspect, the invention provides the use of a substance according to formula (I) or dermatologically acceptable salts thereof, to enhance the cooling effect of physiological coolant-containing compositions.

In formula (I), R⁷ preferably represents hydrogen, C₁-C₃ acyl, C₁-C₃ alkyl or a phosphate group selected from mono-, di- and triphosphate, more preferably hydrogen or a phosphate group as defined above.

More preferably, X represents C₁-C₅ alkyl, C₂-C₅ alkenyl, each optionally substituted with 1-4 hydroxyl groups; R¹ and R² independently represent hydrogen; or C₁-C₅ alkyl or C₂-C₅ alkenyl, each optionally substituted with 1-5 substituents selected from hydroxyl, oxo and C₁-C₃ carboxyl; R³ represents hydrogen; R⁴ represents hydrogen; or C₁-C₆ alkyl, C₂-C₆ alkenyl or C₁-C₆ acyl, each optionally substituted with 1-6 hydroxyl groups; R⁵ and R⁶ independently represent hydrogen, hydroxyl or C₁-C₈ alkyl or C₂-C₈ alkenyl, each substituted with 1-8 hydroxyl groups and R⁷ represents hydrogen, a phosphate group selected from mono-, di-, and triphosphate or a C₂-C₅ carboxyacyl, optionally further substituted with 1-3 substituents selected from hydroxyl, oxo or C₁-C₃ carboxyl.

Still more preferably, X represents C₁-C₂ alkyl, optionally substituted with a hydroxyl group; R¹ and R² independently represent hydrogen or C₁-C₅ alkyl substituted with 1-5 substituents selected from hydroxyl, oxo and C₁-C₃ carboxyl; R⁴ represents hydrogen; or C₁-C₆ alkyl, C₂-C₆ alkenyl or C₁-C₆ acyl, each optionally substituted with 1-6 hydroxyl groups; R⁵ and R⁶ independently represent hydrogen or C₁-alkyl substituted with a hydroxyl group; R³ represents hydrogen; R⁷ represents hydrogen, a phosphate group selected from mono-, di-, and triphosphate or a C₂-C₅ carboxyacyl optionally further substituted with 1-3 substituents selected from hydroxyl, oxo, C₁-C₃ carboxyl.

The present inventors have found that the substances defined here above are very useful ingredients which, in the presence of one or more physiological coolant substances, are capable of imparting highly appreciated cooling sensations to the products in which they are incorporated whilst not behaving as physiological coolants when used in isolation.

Because the coolant-enhancing substances according to the invention are not particularly volatile, they do not produce a strong fragrance impact. However, the enhanced coolant effects observed in compositions comprising the inventive substances allow lower concentrations of physiological coolants to be used, thereby freeing a skilled formulator to prepare compositions that do not have the characteristic minty odour of menthol-containing products and/or to allow greater freedom in creating perfumed products, or enable cost reductions to be made by lowering the concentrations of other, more expensive, physiological coolants.

It was found that particularly satisfying results can be obtained with coolant-enhancing substances according to formula (I) wherein X represents a covalently bound C₁-C₄ alkyl or C₂-C₄ alkenyl chain, each optionally substituted with 1-2 substituents selected from hydroxyl and C₁-C₂ alkyl. More preferably, X represents a C₁-C₃ alkyl chain, optionally substituted with hydroxyl or methyl. Even more preferably, X represents a C₁-C₂ alkyl chain. Most preferably it represents methyl.

Alternatively, R¹ and R² independently represent hydrogen or C₁-C₄ alkyl optionally substituted with 1-5 substituents selected from hydroxyl and oxo, even more preferably R¹ represents hydrogen, methyl, —CH₂—COOH, or —CHOH—COOH and R² represents hydrogen or —CH₂—COOH, such that the coolant-enhancing substances comprise primary amine derivatives of organic food acids, preferably organic acids selected from lactic acid, malic acid, citric acid, glycolic acid and tartaric acid, more preferably tartaric acid and lactic acid.

In still another preferred embodiment R¹ represents C₁-C₄ alkyl, more preferably C₁-C₂ alkyl, most preferably methyl.

A particularly preferred combination is where R¹ represents hydrogen and R² represents methyl.

In the aforementioned formula (I) R⁴ preferably represents hydrogen or C₁-C₄ alkyl, most preferably hydrogen. Likewise, R⁵ preferably represents hydrogen or C₁-C₃ alkyl. Most preferably it represents hydrogen.

Alternatively, it is preferred that R⁴ represents C₁-C₄ alkyl substituted with 1-3 hydroxyl groups, more preferably R⁴ represents 2-hydroxyethyl. In a particularly preferred embodiment R⁴ represents 2-hydroxyethyl, X represents methyl and R⁵ and R⁶ represent hydrogen, such that the coolant-enhancing substances comprise one or more α-hydroxy carboxylic acid derivatives of diethanolamine.

In still another equally preferred embodiment, R¹, R², R³ and Ware chosen such that formula (I) represents a tertiary amine comprising two identical α-hydroxycarboxylic acid residues.

It is generally preferred that R² represents hydrogen or C₁-C₄ alkyl, preferably hydrogen.

According to still another preferred embodiment of the invention X represents methylene, —CHOH—CH₂, or ethylene and R⁵ and R⁶ independently represent methyl, hydroxymethyl or hydrogen. Preferably X represents methylene and R⁵ and R⁶ represents hydrogen. In an even more preferred embodiment R⁵, R⁶ and X together comprise 2 carbon atoms such that the coolant-enhancing substances comprise α-hydroxy carboxylic acid derivatives of amino-propanols and amino-propanediols.

It was found that coolant-enhancing substances according to the present invention wherein R⁷ represents a substituent that is easily deprotonated in aqueous media provide particularly satisfying results. Hence, according to an alternative embodiment R⁷ represents a C₂-C₅ carboxyacyl, optionally substituted with optionally further substituted with 1-3 substituents selected from hydroxyl, oxo, C₁-C₃ carboxyl, such that monoesters of di and tri-carboxylic acids are provided, preferably di- or tricarboxylic acids selected from fumaric acid, tartaric acid, malic acid, citric acid, and aconitic acid.

In another preferred embodiment, R² and/or R⁵ represent hydrogen. Most preferably, both R² and R⁵ represent hydrogen.

Preferred coolant-enhancing substances are selected from the group consisting of N-lactoyl ethanolamide, N-Lactoyl ethanolamide phosphate, N-α-hydroxy-butanoyl ethanolamide, N-α-hydroxy-butanoyl ethanolamide phosphate, N-lactoyl diethanolamide, N-lactoyl-2-amino-1,3-propanediol, N-lactoyl-3-amino-1,2-propanediol, N-lactoyl-3-amino-1-propanol, N-gluconyl-2-amino-1,3-propanediol, N-gluconyl-3-amino-1,2-propanediol, N-mannonyl ethanolamide, N-glycoyl ethanolamide, 2-hydroxyethyl-N-tartaramide, 2-hydroxyethyl-N-malamide or 2-hydroxyethyl-N-citramide.

Preferably the present coolant-enhancing substance is selected from the group consisting of N-lactoyl ethanolamide, N-lactoyl ethanolamide phosphate and N-α-hydroxy-butanoyl ethanolamide, more preferably N-lactoyl ethanolamide.

Suitable physiological coolants include but are not limited to: menthol, menthyl Pyrrolidone carboxylate, menthyl lactate, isopulegol, menthone, N-ethyl p-menthanecarboxamide (WS-3), N,2,3-trimethyl-2-isopropylbutanamide (WS-23), ethyl 2-(2-isopropyl-5methylcyclohexanecarboxamido)-acetate (WS-5), menthone glycerine acetal (Frescolat® MGA), mono-menthyl succinate (Physcool®), mono-menthyl glutarate, O-menthyl glycerine (CoolAct® 10) and 2-sec-butylcyclohexanone (Freskomenthe®), menthane, camphor, pulegol, cineol, mint oil, peppermint oil, spearmint oil, eucalyptus oil, 3-l-menthoxypropane-1,2-diol, 3-l-menthoxy-2-methylpropane-1,2-diol, p-menthane-3,8-diol, 2-l-menthoxyethane-1-ol, 3-l-menthoxypropane-1-ol, and 4-l-menthoxybutane-1-ol, or mixtures thereof. Further examples of cooling compounds can be found e.g. in WO2005/049553 (US2006/0276667A1) (e.g. 2-isopropyl-5-methyl-cyclohexanecarboxylic acid (4-cyanomethyl-phenyl)-amide and 2-isopropyl-5-methyl-cyclohexanecarboxylic acid (4-cyano-phenyl)-amide), WO2006/125334 (e.g. 4-[(2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-benzamide, 3-[(2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]benzamide, and (2-isopropyl-5-methyl-N-(4-(4-methylpiperazine-1-carbonyl)phenyl)cyclohexanecarboxamide) and WO2007/019719 (e.g. 2-isopropyl-5-methyl-cyclohexanecarboxylic acid pyridin-2-ylamide, and 2-isopropyl-5-methyl-cyclohexanecarboxylic acid (2-pyridin-2-yl-ethyl)-amide), which are incorporated herein by reference.

Preferably the physiological coolant is selected from the group consisting of menthyl Pyrrolidone carboxylate, menthyl lactate, menthoxy propanediol, menthlone glycerol ketal, isopulegol, methyl di-isopropyl propionamide and ethyl menthane carboxamide and combinations thereof.

The compositions according to the invention are preferably topically applied cosmetic, toiletry or pharmaceutical compositions, more preferably cosmetic compositions. It is preferred that the compositions are unsuitable for use in the human mouth.

For the present invention, the term “pharmaceutics” refers to products such as those used to impart warmth or cooling to, for example, regions of articular or muscular discomfort or to give relief from the symptoms of fever, nasal congestion etc., but excludes all systemic preparations.

The compositions suitably comprise at least 0.01 wt % of one or more physiological coolant and one or more of the coolant-enhancing substances as defined herein in an amount of at least 0.005 wt. %, more preferably at least 0.05 wt. %. Preferably the amount of the present coolant-enhancing substances does not exceed 20 wt. %, more preferably it does not exceed 10 wt. %, and most preferably it does not exceed 5%.

Typically, in the compositions according to the invention, the coolant-enhancing substances and physiological coolants substances as defined herein before are employed in a weight ratio within the range of 2000:1 to 1:200, more preferably in a weight ratio of between 20:1 and 1:2, and most preferably in a weight ratio of between 20:1 and 2:5.

The compositions according to the present invention may suitably be prepared in any convenient form. In one preferred embodiment compositions are provided comprising N-Lactoyl ethanolamide as well as menthyl pyrrolidone carboxylate, also known as menthyl PCA. Menthyl PCA is available from Quest International under the trade name Questice®.

In another preferred embodiment of the present invention compositions are provided comprising N-Lactoyl ethanolamide as well as menthol.

In still another preferred embodiment compositions are provided comprising N-Lactoyl ethanolamide as well as other physiological cooling agents, such as menthyl lactate, menthyl glyceryl ether, menthone glyceryl ketal, and the like.

These examples are for the purpose of illustration only and it is understood that variations and modifications can be made by one skilled in the art without departing from the spirit and the scope of the invention. It should be understood that the embodiments described are not only in the alternative, but can be combined.

EXAMPLE 1

A simple aqueous ethanol solution (50:50) containing 1% by weight of lactoyl ethanolamide was applied to one forearm. The aqueous ethanol solution alone (control) was then applied to the other forearm at a similar dosage, and the perception of cooling from either arm noted. This was repeated on 10 volunteers in total.

The results showed no difference in cooling perception between the test solution, containing lactoyl ethanolamide, and the placebo solution.

EXAMPLE 2

A simple aqueous ethanol solution (50:50) containing 0.2% by weight of L-menthol and 1% by weight of lactoyl ethanolamide was applied to one forearm at a concentration of 2 drops per 10 square centimetres of skin. The aqueous ethanol solution containing just 0.2% by weight L-menthol was then applied to the other forearm at the same dose, and the perception of cooling from either arm noted. This was repeated on 10 volunteers.

The results showed a higher cooling perception was felt from the solution containing lactoyl ethanolamide.

EXAMPLE 3

A simple aqueous ethanol solution (50:50) containing 0.2% by weight of L-menthol and 0.5% by weight of lactoyl ethanolamide was applied to one forearm at a concentration of 2 drops per 10 square centimetres of skin. The aqueous ethanol solution containing 0.2% by weight L-menthol was then applied to the other forearm at the same dose, and the perception of cooling from either arm noted over 4 hours at 30 minute intervals. This was repeated on 12 volunteers.

The results showed a higher cooling perception was felt from the solution containing L-menthol and lactoyl ethanolamide. In addition, the cooling was felt over a longer period of time (for over 3 hours) with the solution containing L-menthol and lactoyl ethanolamide. The solution containing just L-menthol provided a cooling sensation for only about 2 hours.

EXAMPLE 4

A simple aqueous ethanol solution (50:50) containing 1% by weight of menthyl lactate and 1% by weight of lactoyl ethanolamide was applied to one forearm at a concentration of 2 drops per 10 square centimetres of skin. The aqueous ethanol solution containing 1% by weight menthyl lactate was then applied to the other forearm at the same dose, and the perception of cooling from either arm noted over 4 hours at 30 minute intervals. This was repeated on 12 volunteers.

The results showed a higher cooling perception was felt from the solution containing menthyl lactate and lactoyl ethanolamide. In addition, the cooling was felt over a longer period of time (for over 3 hours) with the solution containing menthyl lactate and lactoyl ethanolamide. The solution containing just menthyl lactate provided a cooling sensation for only about 2 hours.

EXAMPLE 5

A simple aqueous ethanol solution (50:50) containing 1.0% by weight of menthone glyceryl ketal and 0.5% by weight of lactoyl ethanolamide was applied to one forearm at a concentration of 2 drops per 10 square centimetres of skin. The aqueous ethanol solution containing 1% by weight menthone glyceryl ketal was then applied to the other forearm at the same dose, and the perception of cooling from either arm noted over 4 hours at 1 hour intervals. This was repeated on 10 volunteers.

The results showed a higher cooling perception was felt from the solution containing menthone glyceryl ketal and lactoyl ethanolamide. In addition, the cooling was felt over a longer period of time (for over 4 hours) with the solution containing menthone glyceryl ketal and lactoyl ethanolamide. The solution containing just menthone glyceryl ketal provided a cooling sensation for only about 3 hours.

EXAMPLE 6

A simple aqueous ethanol solution (50:50) containing 0.75% by weight of menthyl glyceryl ether and 0.5% by weight of lactoyl ethanolamide was applied to one forearm at a concentration of 2 drops per 10 square centimetres of skin. An aqueous ethanol solution containing 1% by weight menthyl glyceryl ether was then applied to the other forearm at the same dose, and the perception of cooling from either arm noted over a 4 hour period. This was repeated on 12 volunteers.

The results showed a similar cooling perception was felt from the two solutions; the addition of lactoyl ethanolamine allows the reduction of the expensive physiological coolant, in this case menthyl glyceryl ether.

EXAMPLE 7

A simple aqueous ethanol solution (50:50) containing 1% by weight of menthyl pyrrolidone carboxylate and 0.5% by weight of lactoyl ethanolamide was applied to one forearm at a concentration of 2 drops per 10 square centimetres of skin. An aqueous ethanol solution containing 1% by weight menthyl pyrrolidone carboxylate was then applied to the other forearm at the same dose and the perception of cooling from either arm noted over a 6 hour period. This was repeated on 33 volunteers.

The results showed a higher level of cooling was obtained with the presence of lactoyl ethanolamine and that the improved cooling perception was sustained for at least 6 hours.

EXAMPLE 8 Cooling Liquid Talc

A light, moisturising lotion containing talc and a physiological coolant to keep you dry and fresh all day.

Formulation: % w/w Water to 100.00 Menthyl Pyrrolidone Carboxylate 2.00 LACTOYL ETHANOLAMIDE 1.00 Cyclomethicone & Dimethiconol 2.00 Talc 2.00 Cetearyl Alcohol & PEG-20 Stearate 1.50 Capric/Caprylic Triglyceride 1.50 Aluminium Starch Octenylsuccinate 1.00 Cetearyl Alcohol 0.60 Triethanolamine 0.50 Carbomer 0.20 Preservative q.s.

Method:

Add to the water the Carbomer and allow to wet out. Heat to 65° C.

Combine the remaining ingredients and heat to 65° C.

Add the oils to the water phase with high shear.

Stir cool and add preservative and fragrance as required.

EXAMPLE 9 Deodorising Foot Spray

A deodorising spray to cool and refresh the feet. It provides physiological cooling and emolliency to leave the skin fresh and soft for hours to come.

Formulation: % w/w Ethanol to 100.00 Diispropyl Dimer Dilinoleate 3.00 Menthyl Lactate 1.50 Fractionated Coconut Oil 1.00 Triclosan 0.30 Menthol 0.20 LACTOYL ETHANOLAMIDE 1.00 Perfume q.s.

Method:

Dissolve the triclosan, menthol and methyl lactate sequentially into the ethanol. Add the remaining ingredients with stirring.

This product can be filled directly into pump sprays, or filled as an aerosol with a butane propellant.

EXAMPLE 10 Aftersun Cream Gelee

A light cream gel that absorbs without excessive rubbing of tender areas. Its cooling effect is due to Menthyl PCA and Lactoyl Ethanolamine, creating a pleasant feel to skin irritated by the sun.

% w/w Phase A Water to 100.00 Hydroxypropylcellulose 0.40 Carbomer 0.20 Phase B Isostearyl Alcohol 1.20 Menthyl Pyrrolidone Carboxylate 1.50 LACTOYL ETHANOLAMIDE 1.00 Preservative q.s. Tetrahydroxypropyl Ethylenediamine 0.30 Perfume q.s.

Method

Combine the Hydroxypropylcellulose and water and mix under high shear for one hour so as to allow it to be fully hydrated (i.e. the water must be crystal clear). Add the carbomer and mix.

In a separate vessel, add the Menthyl Pyrrolidone Carboxylate, Lactoyl Ethanolamide and the Tetrahydroxypropyl Ethylenediamine. Once this is mixed, add the preservative, Isostearyl Alcohol and perfume. When this mixture is homogenous, add it to phase A and high shear until smooth. The resulting cream gelee should have a pH within the range 6.0 and 6.5.

EXAMPLE 11 Refreshing Leg Gel

A light gel that provides a refreshing, cooling feel to ‘tired’ legs.

% w/w Phase A Water to 100.00 Ethanol 40.00  Carbomer 0.50 Phase B Menthyl Glyceryl Ether 1.00 LACTOYL ETHANOLAMIDE 1.00 Preservative q.s. Triethanolamine 0.45 Perfume q.s.

Method

Combine the Carbomer to the water and mix under until the carbomer is dispersed. Add the Ethanol and allow any bubbles to separate.

Then stir in the Menthyl Glyceryl Ether, followed by the Lactoyl Ethanolamide, the preservative and the fragrance. Finally, add the triethanolamine and stir until the gel is transparent.

The resulting gel should have a pH within the range 6.0 and 6.5. 

1. A composition comprising a physiological coolant and one or more coolant-enhancing substances according to formula (I) and/or physiologically or dermatologically acceptable salts thereof: R¹CR²(OR³)—CO—NR⁴—CR⁵R⁶—X—OR⁷  (I) wherein: X represents a covalently bound radical comprising C₁-C₅ alkyl or C₂-C₅ alkenyl, each covalently bound radical optionally substituted with 1-4 substituents selected from hydroxyl, C₁-C₃ alkyl or C₂-C₃ alkenyl; R¹ and R² independently represent hydrogen; C₁-C₈ alkyl; C₂-C₅ alkenyl; or C₃-C₈ cycloalkyl, each optionally substituted with 1-8 substituents selected from hydroxyl, oxo, C₁-C₃ alkyl, C₂-C₃ alkenyl or C₁-C₃ carboxyl; R³ represents hydrogen, C₁-C₃ acyl or C₁-C₃ alkyl; R⁴ represents hydrogen; C₁-C₆ alkyl, C₂-C₆ alkenyl, C₃-C₆ cycloalkyl, C₃-C₆ cycloalkenyl, or C₁-C₆ acyl, each optionally substituted with 1-6 substituents selected from hydroxyl, C₁-C₃ alkyl or C₂-C₃ alkenyl; R⁵ and R⁶ independently represent hydrogen; hydroxyl; C₁-C₈ alkyl; C₂-C₈ alkenyl or C₃-C₈ cycloalkyl, each optionally substituted with 1-8 substituents selected from hydroxyl, C₁-C₃ alkyl or C₂-C₃ alkenyl; R⁷ represents hydrogen, C₁-C₃ acyl, C₁-C₃ alkyl, a phosphate group selected from mono-, di- or triphosphate, or a C₂-C₅ carboxyacyl, or optionally substituted with 1-3 substituents selected from hydroxyl, oxo, C₁-C₃ carboxyl; provided that R¹—CR²(OR³)—CO— does not represent a hexose or heptose sugar acid residue comprising more than four hydroxyl groups.
 2. The composition according to claim 1, wherein R⁷ represents hydrogen, C₁-C₃ acyl, C₁-C₃ alkyl or a phosphate group selected from mono-, di- and triphosphate.
 3. The composition according to claim 1, wherein X represents a covalently bound radical selected from the group comprising C₁-C₅ alkyl or C₂-C₅ alkenyl, each optionally substituted with 1-4 hydroxyl groups; R¹ and R² independently represent hydrogen; C₁-C₅ alkyl or C₂-C₅ alkenyl, each optionally substituted with 1-5 substituents selected from hydroxyl, oxo and C₁-C₃ carboxyl; R³ represents hydrogen; R⁴ represents hydrogen; C₁-C₆ alkyl, C₂-C₆ alkenyl or C₁-C₆ acyl, each optionally substituted with 1-6 hydroxyl groups R⁵ and R⁶ independently represent hydrogen; hydroxyl; C₁-C₈ alkyl; or C₂-C₈ alkenyl, each substituted with 1-8 hydroxyl groups; R⁷ represents hydrogen; a phosphate group selected from mono-, di- and triphosphate; or a C₂-C₅ carboxyacyl optionally substituted with 1-3 substituents selected from hydroxyl, oxo, C₁-C₃ carboxyl.
 4. The composition according to claim 3, wherein X represents a covalently bonded C₁-C₂ alkyl radical, optionally substituted with a hydroxyl group; R¹ and R² independently represent hydrogen or C₁-C₅ alkyl substituted with 1-5 substituents selected from hydroxyl, oxo and C₁-C₃ carboxyl R³ represents hydrogen; R⁴ represents hydrogen; C₁-C₆ alkyl, C₂-C₆ alkenyl or C₁-C₆ acyl, each optionally substituted with 1-6 hydroxyl groups R⁵ and R⁶ independently represent hydrogen or C₁ alkyl substituted with a hydroxyl group; R⁷ represents hydrogen; a phosphate group selected from mono-, di- and triphosphate; or a C₂-C₅ carboxyacyl optionally substituted with 1-3 substituents selected from hydroxyl, oxo, or C₁-C₃ carboxyl.
 5. The composition according to claim 1, wherein X represents a covalently bound C₁-C₃ alkyl, optionally substituted with hydroxyl or methyl.
 6. The composition according to claim 1, wherein R¹ and R² independently represent hydrogen or C₁-C₄ alkyl, optionally substituted with 1-5 substituents selected from hydroxyl and oxo.
 7. The composition according to claim 6, wherein R¹ represents hydrogen and R² represents methyl.
 8. The composition according to claim 1, wherein R⁴ represents hydrogen or C₁-C₄ alkyl substituted with 1-3 hydroxyl groups.
 9. The composition according to claim 1, wherein R² represents hydrogen or C₁-C₄ alkyl, preferably hydrogen.
 10. The composition according to claim 1, wherein X represents methylene and R⁵ and R⁶ represent hydrogen.
 11. The composition according to claim 1, wherein the composition is a cosmetic composition.
 12. The composition according to claim 1, wherein the composition comprises at least 0.01 wt % of the physiological coolant.
 13. The composition according to claim 1, wherein the composition comprises at least 0.005 wt % of the one or more coolant-enhancing substances according to formula (I).
 14. The composition according to claim 1, wherein the physiological coolant is selected from the group consisting of menthol, menthyl Pyrrolidone carboxylate, menthyl lactate, menthoxy propanediol, menthone glycerol ketal, isopulegol, methyl di-isopropyl propionamide and ethyl menthane carboxamide and combinations thereof.
 15. The composition according to claim 1, wherein the physiological coolant is selected from the group consisting of menthyl Pyrrolidone carboxylate, menthyl lactate, menthoxy propanediol, menthone glycerol ketal, isopulegol, methyl di-isopropyl propionamide and ethyl menthane carboxamide and combinations thereof.
 16. The composition according to claim 1, wherein the cooling-enhancing substance is selected from the group consisting of N-lactoyl ethanolamide, N-lactoyl ethanolamide phosphate, N-α-hydroxy-butanoyl ethanolamide phosphate, N-lactoyl diethanolamide, N-lactoyl-2-amino-1,3-propanediol, N-lactoyl-3-amino-1,2-propanediol, N-lactoyl-3-amino-1-propanol, N-gluconyl-2-amino-1,3-propanediol, N-gluconyl-3-amino-1,2-propanediol, N-mannonyl ethanolamide, N-glycoyl ethanolamide, 2-hydroxyethyl-N-tartaramide, 2-hydroxyethyl-N-malamide, and 2-hydroxyethyl-N-citramide and mixtures thereof.
 17. The composition to claim 16, wherein the cooling-enhancing substance is selected from the group consisting of N-lactoyl ethanolamide, N-lactoyl ethanolamide phosphate and N-α-hydroxy-butanoyl ethanolamide.
 18. The composition according to claim 17, wherein the cooling-enhancing substance is N-lactoyl ethanolamide.
 19. The composition according to claim 1, wherein the composition is unsuitable for use in the human mouth.
 20. A method of providing a cooling sensation to the skin, the method comprising topically applying the composition of claim 1 to the skin. 